In_Vivo experiment designed to assess clinical efficacy targeting PVALB in APP/PS1 mice 8-11 months (n=10/group x 3 groups) with hippocampal LFP implants; MRI-guided tFUS. Primary outcome: Perivascular Abeta load around PV+ cells reduced >=35%; CA1 gamma power restored to >=70% of WT
tFUS will increase glymphatic influx 2x (gadolinium signal), reduce PV-soma-adjacent Abeta >=35%, restore CA1 gamma >=70% WT, and improve Barnes maze latency.
Primary: PV perisomatic Abeta area fraction reduced >=35% vs APP/PS1-sham (p<0.05). Secondary: CA1 gamma power >=70% of WT level; no T2 lesions on MRI.
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.